Gonadotropin releasing hormone receptor antagonist - Bayer HealthCareAlternative Names: GnRH antagonist
Latest Information Update: 30 May 2016
At a glance
- Originator Bayer HealthCare
- Mechanism of Action LHRH receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Uterine leiomyoma
Most Recent Events
- 30 Sep 2014 Phase-I clinical trials in Uterine leiomyoma in Germany (unspecified route)